UAE Orders Recall Of Hospira's Paclitaxel Cancer Chemo Drug
This article was originally published in PharmAsia News
Executive Summary
Abu Dhabi's Health Authority, acting in response to a U.S. FDA recall, ordered a UAE-wide recall of paclitaxel because of glass particles found in at least one batch of the injectable drug used in ovarian- and breast-cancer chemotherapy.